The United States Coordinating Body has approved a second treatment for coronavirus. Yesterday, the agency officially approved the pill offered by Pfizer, which is also intended to treat coronavirus at home.
The joint product of Merck և Ridgeback Biotherapeutics is called “Molunpiravir”, it is already widely used in the UK. It has not yet been officially approved by the relevant bodies in the European Union.
Experts estimate that Pfizer և Merck pills are most likely to be effective in the “omicron” strain, as both drugs target the S-protein, which contains most of the most troubling mutations in the strain.